Article Text

Download PDFPDF
Review: regular inhaled short acting β2 agonists improve lung function in stable chronic obstructive pulmonary disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

OpenUrlAbstract/FREE Full Text

Q Is regular treatment with inhaled short acting β2 agonists (ISABAs) effective for stable chronic obstructive pulmonary disease (COPD)?


Embedded ImageData sources:

Cochrane Collaboration trials register up to and including May 2002 and reference lists of review articles and retrieved studies.

Embedded ImageStudy selection and assessment:

randomised, placebo controlled trials of ISABAs given to patients with stable COPD for ⩾7 days. Individual study quality was assessed on the basis of allocation concealment.

Embedded ImageOutcomes:

forced expiratory volume in 1 second (FEV1 …

View Full Text


  • A modified version of this abstract appears in ACP Journal Club.

  • For correspondence: Dr F S F Ram, National Collaborating Centre of Women and Children’s Health, London, UK.

  • Source of funding: the Netherlands Asthma Foundation.